Tetra Pharm Technologies Relocates to Copenhagen Towers

COPENHAGEN, Denmark, Sept. 18, 2024 /PRNewswire/ — Tetra Pharm Technologies are thrilled to announce the relocation of headquarters to Copenhagen Towers in Copenhagen. Effective October 1st, 2024, this strategic move reflects the company´s commitment to growth, accessibility, and collaboration.

“Driven by our vision for innovation, we’ve chosen Copenhagen Towers as our new home. Its vibrant business ecosystem and exceptional amenities align perfectly with our mission”, says Jesper Breum, COO, Tetra Pharm Technologies.

Copenhagen Towers, strategically positioned in Copenhagen, offers unparalleled connectivity. Proximity to major transportation hubs, such as Copenhagen airport, ensures seamless interactions with partners, clients, and stakeholders.

Collaborations and partnerships within the pharmaceutical industry, as well as with research institutions and regulatory agencies, are driving drug innovation.

“By combining expertise, sharing resources, and fostering knowledge exchange, collaborations are cultivating innovation and propelling advancements in healthcare”, CEO Martin Rose states.

Designed by Foster & Partners, the Towers embody Tetra Pharm´s commitment to cutting-edge solutions.

Tetra Pharm Technologies’ management, employees, and partners eagerly anticipate this transition.

“We invite everyone to join us in this exciting chapter.” Martin Rose adds.

The official move to Copenhagen Towers is scheduled for October 1st, 2024.

For media inquiries contact:

PR Manager Tue Wettergreen Paltorp
Email: tue.paltorp@tetrapharm.eu
Phone: +45-31441969

Photo – https://healthtechnologynet.com/wp-content/uploads/2024/09/Copenhagen_Towers.jpg
Logo – https://healthtechnologynet.com/wp-content/uploads/2024/09/TPT_Logo.jpg

View original content to download multimedia:https://www.prnewswire.com/news-releases/tetra-pharm-technologies-relocates-to-copenhagen-towers-302249209.html

SOURCE Tetra Pharm Technologies

Staff

Recent Posts

Medtronic announces filing of IPO registration statement for Diabetes business, MiniMed

GALWAY, Ireland, Dec. 19, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in…

13 hours ago

Pinealage: the app that turns strangers into meditation companions — in crowdfunding phase

This app will connect people with strangers to meditate together in the real world—an invitation…

13 hours ago

IMG Saxony-Anhalt: 2026 in Sight – Saxony-Anhalt Sets the Pace for Future Industries

Despite challenging framework conditions such as high energy prices, the international introduction of tariffs, and…

13 hours ago

Kirby Medical Center Partners with Switchboard, MD to Automate Patient Communication Workflows

ATLANTA, Dec. 19, 2025 /PRNewswire/ -- Switchboard, MD is proud to announce a new enterprise partnership with…

13 hours ago

SIERRA7 RECOGNIZED AS A 2026 ELEV8 GOVCON AWARD WINNER

MCLEAN, Va., Dec. 19, 2025 /PRNewswire/ -- Sierra7, a leader in government healthcare and technology solutions,…

13 hours ago

Medome Launch Heralds the End of Medical Misdiagnoses and Lost Lives

NEW YORK, Dec. 19, 2025 /PRNewswire/ -- Medome is the first AI technology for Personal Health…

13 hours ago